Cargando…

Regulation of VEGFR2 and AKT signaling by Musashi-2 in lung cancer

Mostrar otras versiones (1)

Lung cancer is the most frequently diagnosed cancer type and the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) represents most of the lung cancer. Vascular endothelial growth factor receptor-2 (VEGFR2) is a member of the VEGF family of receptor tyrosine kinase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bychkov, Igor, Topchu, Iuliia, Makhov, Petr, Kudinov, Alexander, Patel, Jyoti D., Boumber, Yanis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081235/ https://www.ncbi.nlm.nih.gov/pubmed/37034813 http://dx.doi.org/10.1101/2023.03.29.534783

Ejemplares similares

Regulation of VEGFR2 and AKT Signaling by Musashi-2 in Lung Cancer
por: Bychkov, Igor, et al.
Publicado: (2023)

NSD1 supports cell growth and regulates autophagy in HPV-negative head and neck squamous cell carcinoma
por: Topchu, Iuliia, et al.
Publicado: (2023)

Musashi-2 (MSI2) regulates epidermal growth factor receptor (EGFR) expression and response to EGFR inhibitors in EGFR-mutated non-small cell lung cancer (NSCLC)
por: Makhov, Petr, et al.
Publicado: (2021)

Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)
por: Topchu, Iuliia, et al.
Publicado: (2021)

Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry
por: Bai, Nan, et al.
Publicado: (2023)

Rationally designed inhibitors of the Musashi protein-RNA interaction by hotspot mimicry
por: Bai, Nan, et al.
Publicado: (2023)

Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression
por: Kharin, Leonid, et al.
Publicado: (2021)

The Prognostic and Therapeutic Potential of DNA Damage Repair Pathway Alterations and Homologous Recombination Deficiency in Lung Cancer
por: Khaddour, Karam, et al.
Publicado: (2022)

Case report: reinitiating pembrolizumab treatment after small bowel perforation
por: Beck, Tim N., et al.
Publicado: (2019)

Impact of Musashi-1 and Musashi-2 Double Knockdown on Notch Signaling and the Pathogenesis of Endometriosis
por: Strauß, Theresa, et al.
Publicado: (2022)

The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma
por: Makhov, Peter, et al.
Publicado: (2018)

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors
por: Khaddour, Karam, et al.
Publicado: (2020)

Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies
por: Khaddour, Karam, et al.
Publicado: (2021)

FRI291 Musashi1 And Musashi2 Mark Distinct Pituitary Stem Cell Populations
por: Rahmatallah, Yasir, et al.
Publicado: (2023)

Design, synthesis and biological evaluation of 2-quinolyl-1,3-tropolone derivatives as new anti-cancer agents
por: Gusakov, Evgeniy A., et al.
Publicado: (2021)

Rutacecarpine Inhibits Angiogenesis by Targeting the VEGFR2 and VEGFR2-Mediated Akt/mTOR/p70s6k Signaling Pathway
por: Ji, Lijun, et al.
Publicado: (2018)

Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC)
por: Deneka, Alexander Y., et al.
Publicado: (2019)

Tau oligomers mediate aggregation of RNA‐binding proteins Musashi1 and Musashi2 inducing Lamin alteration
por: Montalbano, Mauro, et al.
Publicado: (2019)

CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma
por: Makhov, Peter, et al.
Publicado: (2020)

Musashi-2 Attenuates AHR Signaling to Expand Human Hematopoietic Stem Cells
por: Rentas, Stefan, et al.
Publicado: (2016)

Musashi-1 regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and chemoresistance in glioblastoma
por: Chen, Hsiao-Yun, et al.
Publicado: (2016)

Cigarette smoke regulates VEGFR2-mediated survival signaling in rat lungs
por: Marwick, John A, et al.
Publicado: (2010)

Sinensetin suppresses angiogenesis in liver cancer by targeting the VEGF/VEGFR2/AKT signaling pathway
por: Li, Xiao, et al.
Publicado: (2022)

Toroidally focused sensor array for real-time laser-ultrasonic imaging: The first experimental study
por: Bychkov, Anton, et al.
Publicado: (2019)

Musashi-2 controls cell fate, lineage bias, and TGF-β signaling in HSCs
por: Park, Sun-Mi, et al.
Publicado: (2014)

Lovastatin Inhibits VEGFR and AKT Activation: Synergistic Cytotoxicity in Combination with VEGFR Inhibitors
por: Zhao, Tong T., et al.
Publicado: (2010)

Antiangiogenic properties of caudatin in vitro and in vivo by suppression of VEGF-VEGFR2-AKT/FAK signal axis
por: Wang, Xinzhi, et al.
Publicado: (2017)

Angiostatic actions of capsicodendrin through selective inhibition of VEGFR2-mediated AKT signaling and disregulated autophagy
por: Pan, Christopher C., et al.
Publicado: (2016)

Evasion of regulatory phosphorylation by an alternatively spliced isoform of Musashi2
por: MacNicol, Melanie C., et al.
Publicado: (2017)

Small Molecule Palmatine Targeting Musashi-2 in Colorectal Cancer
por: Zhang, Xue, et al.
Publicado: (2022)

RNA-Binding Protein Musashi-2 Inhibits Aldosterone Production
por: Bartholomay, Kathryn, et al.
Publicado: (2021)

Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma
por: Sureda-Gómez, Marta, et al.
Publicado: (2022)

VEGFR-2 reduces while combined VEGFR-2 and -3 signaling increases inflammation in apical periodontitis
por: Virtej, Anca, et al.
Publicado: (2016)

Computational Model of Gab1/2-Dependent VEGFR2 Pathway to Akt Activation
por: Tan, Wan Hua, et al.
Publicado: (2013)

Microtubules Coordinate VEGFR2 Signaling and Sorting
por: Czeisler, Catherine, et al.
Publicado: (2013)

NEDD9 Restrains dsDNA Damage Response during Non-Small Cell Lung Cancer (NSCLC) Progression
por: Tikhomirova, Mariya, et al.
Publicado: (2022)

Editing VEGFR2 Blocks VEGF-Induced Activation of Akt and Tube Formation
por: Huang, Xionggao, et al.
Publicado: (2017)

Association between EGFR/KRAS mutation and expression of VEGFA, VEGFR and VEGFR2 in lung adenocarcinoma
por: Yuan, Xiao-Han, et al.
Publicado: (2018)

Structural Insight into the Recognition of r(UAG) by Musashi-1 RBD2, and Construction of a Model of Musashi-1 RBD1-2 Bound to the Minimum Target RNA
por: Iwaoka, Ryo, et al.
Publicado: (2017)

Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma
por: Jinnin, Masatoshi, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_qvl6kc07f05sikqsgvcbend1sa